18714317

Source:http://linkedlifedata.com/resource/pubmed/id/18714317

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0031325, umls-concept:C0043031, umls-concept:C0243095, umls-concept:C0282655, umls-concept:C0679199, umls-concept:C2698651
pubmed:issue	3
pubmed:dateCreated	2008-8-20
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18714317-18714318
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372741
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Aryl Hydrocarbon Hydroxylases, http://linkedlifedata.com/resource/pubmed/chemical/CYP2C9 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Warfarin
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1532-6535
pubmed:author	pubmed-author:LeskoL JLJ
pubmed:issnType	Electronic
pubmed:volume	84
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	301-3
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:18714317-Aged, pubmed-meshheading:18714317-Anticoagulants, pubmed-meshheading:18714317-Aryl Hydrocarbon Hydroxylases, pubmed-meshheading:18714317-Cost-Benefit Analysis, pubmed-meshheading:18714317-Dose-Response Relationship, Drug, pubmed-meshheading:18714317-Genetic Testing, pubmed-meshheading:18714317-Humans, pubmed-meshheading:18714317-Pharmacogenetics, pubmed-meshheading:18714317-Warfarin
pubmed:year	2008
pubmed:articleTitle	The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics.
pubmed:affiliation	Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA. lawrence.lesko@fda.hhs.gov
pubmed:publicationType	Journal Article, Review